Zhengye Biotechnology Holding reported total assets of $62.39M and total liabilities of $18.55M for the quarter ended Dec 2025. This balance sheet covers 4 quarters of results from Dec 2023 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Dec2023 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|
| Assets | ||||
| Current Assets | ||||
| Cash & EquivalentsCash & Equiv. | 3.83M | 2.55M | 6.37M | 7.19M |
| Short-term InvestmentsInvestments (Current) | 0.17M | 0.20M | 0.28M | 0.22M |
| Cash & Current Investments | 4.00M | 0.20M | 0.11M | 7.42M |
| Receivables - NetNet Receivables | 10.44M | 8.16M | 5.16M | 2.64M |
| Receivables - OtherOther Receivables | 0.18M | 0.10M | 0.10M | 0.11M |
| Receivables | 10.62M | 8.26M | 5.25M | 2.75M |
| Raw Materials | 1.39M | 1.02M | 1.13M | |
| Work In Process | 4.72M | 4.53M | 2.53M | |
| Finished Goods | 2.09M | 2.43M | 1.94M | |
| Inventory | 8.20M | 7.98M | 7.48M | 5.60M |
| Prepaid Assets | 0.36M | 3.59M | 3.67M | |
| Current Assets | 26.63M | 24.33M | 28.12M | 19.64M |
| Non-Current Assets | ||||
| Buildings | 21.36M | 20.96M | 22.40M | |
| Construction in Progress | 1.07M | 1.34M | 0.09M | |
| Property, Plant & Equipment (Net)PP&E (Net) | 37.04M | 34.96M | 34.44M | 33.85M |
| Long-Term Investments | 38.39M | 38.91M | 30.95M | |
| Intangibles | 2.29M | 2.03M | 2.15M | 6.73M |
| Goodwill & Intangibles | 2.29M | 2.03M | 2.14M | 6.73M |
| Long-Term Deferred Tax | 1.68M | 1.51M | 2.28M | 0.07M |
| Other Non-Current Assets | 1.55M | 3.66M | 2.37M | 1.00M |
| Non-Current Assets | 43.71M | 43.26M | 42.32M | 42.75M |
| Assets | 70.34M | 67.59M | 70.44M | 62.39M |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payables | 6.42M | 5.89M | 5.98M | 6.29M |
| Notes Payables | 11.24M | 10.20M | 11.29M | 9.31M |
| Dividends payables | 2.20M | 0.28M | 0.30M | |
| Payables | 19.86M | 16.37M | 17.55M | 15.60M |
| Accumulated Expenses | 0.41M | 0.35M | 0.53M | 0.49M |
| Other Accumulated Expenses | 0.12M | 0.08M | 0.06M | 0.06M |
| Short term Debt | 0.99M | 0.03M | 0.10M | |
| Current Taxes | 0.32M | 0.28M | 0.30M | 0.34M |
| Current Deferred Revenue | 0.55M | 0.48M | 0.70M | 0.68M |
| Total Current Liabilities | 21.14M | 18.62M | 18.82M | 17.22M |
| Non-Current Liabilities | ||||
| Non-Current Debt | 1.41M | 0.66M | 0.66M | 1.26M |
| Minority Interest | 9.35M | 9.40M | 9.24M | 8.13M |
| Non-Current Deferred Tax LiabilityNon-Current Deferred Tax | 0.01M | |||
| Operating Leases | 0.05M | |||
| Other Non-Current Liabilities | 0.02M | 4.67M | ||
| Total Non-Current Liabilities | 1.46M | 0.66M | 0.66M | 1.33M |
| Total Liabilities | 22.60M | 19.28M | 19.46M | 18.55M |
| Shareholder's Equity | ||||
| Total Debt | 12.64M | 11.84M | 11.96M | 10.67M |
| Common Equity | 47.74M | 48.31M | 50.97M | 43.84M |
| Liabilities and Shareholders Equity | 70.34M | 67.59M | 70.36M | 62.39M |
| Retained Earnings | 5.40M | 6.60M | 3.70M | -3.09M |
Pull Zhengye Biotechnology Holding's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=ZYBT&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "ZYBT", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=ZYBT&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();